Elite Pharmaceuticals, Inc. (OTCQB: ELTP) is a specialty pharmaceutical companydeveloping a pipeline of proprietary pharmacological abuse-deterrent opioid products and niche generic products. Elite specializes in oral sustained and controlled release drug products with high barriers to entry. The company has eight commercial products currently being sold, several additional approved products pending manufacturing site transfer, and an additional product under review pending approval by the FDA. For more information, visit the company’s website at www.elitepharma.com.